naion with semaglutide NAION is a very rare side effect of semaglutide - NAION semaglutideReddit Semaglutide Understanding the Relationship Between Semaglutide and NAION Risk

NAIONtirzepatide The use of semaglutide, a widely prescribed medication for type 2 diabetes and obesity, has raised concerns regarding its potential association with Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)Association between Semaglutide and Nonarteritic Anterior .... While research in this area is ongoing, a growing body of evidence suggests a possible link between semaglutide and an increased risk of NAION. This article aims to synthesize current findings, explore the potential mechanisms, and provide guidance for patients prescribed semaglutide.作者：J Grauslund·2024·被引用次数：72—In conclusion, we have demonstrated in a five-year national cohort study thatuse of once-weekly semaglutide more than doubles the risk of NAION...

NAION is a serious eye condition that affects the optic nerve, leading to sudden and often permanent vision loss in one or both eyesSemaglutide Use Increases NAION Risk in Patients With .... It occurs when blood flow to the optic nerve is interrupted, causing damageSystemic Review ของ RCTs ทั้งหมดของ Semaglutide กับ .... While several factors can contribute to NAION, including age, vascular risk factors like diabetes and high blood pressure, and certain medications, the emergence of semaglutide as a potential factor warrants careful considerationOnce-weekly semaglutide doubles the five-year risk of ....

Several studies have investigated the association between Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy1天前—“Clinicians and patients should be counseled on therare but evident increased risk of NAION after semaglutide initiation.” Three authors .... Some research indicates a higher risk of NAION in patients prescribed semaglutide compared to those on other medications. For instance, one matched cohort study involving 16,827 patients revealed this heightened risk. Another study found that the use of once-weekly semaglutide more than doubles the risk of NAION.Is Semaglutide Use Associated with Nonarteritic Anterior ... The European Medicines Agency (EMA) has acknowledged that NAION is a very rare side effect of semaglutide, potentially affecting up to 1 in 10,000 users. This implies that while infrequent, the risk is "rare but evident."

However, it is crucial to note that not all studies have found a definitive link.Nonarteritic Anterior Ischemic Optic Neuropathy and ... Some research suggests that semaglutide may not be associated with an increased risk of NAION in the general population. Furthermore, one study concluded that there was no significant increase in risk of NAION or ION in patients taking semaglutide or GLP-1 RAs compared to T2DM or high BMI controls.Association between Semaglutide and Nonarteritic Anterior ... These differing findings highlight the complexity of the issue and the need for further investigation.

When considering the risk, certain patient groups may be more susceptible. Patients with type 2 diabetes (T2D) and obesity are already at a higher baseline risk for NAION. In these populations, semaglutide use is linked with a greater risk of nonarteritic anterior ischemic optic neuropathy.Specialists discuss concerns over impact of semaglutide ... Specifically, rates of NAION have been found to be 4.28 and 7.64 times higher for individuals with type 2 diabetes and obesity, respectively, when using semaglutide.佛历2568年6月27日—PRAC concluded thatNAION is a very rare side effect of semaglutide, potentially affecting up to 1 in 10,000 users. Accordingly, EMA has ... For patients with type 2 diabetes on semaglutide, the cumulative 5-year risk of NAION was reported at 0.065%.Semaglutide and Nonarteritic Anterior Ischemic Optic ... - PMC In those with high BMI prescribed semaglutide, the risks of NAION and ION after two years were 0.038% and 0.404%, respectively. One study even reported an increased absolute risk of NAION of 7.5% in patients with T2DM and 7% in individuals using a semaglutide.

The mechanism by which semaglutide might influence NAION risk is not fully understood. Semaglutide, as a GLP-1 receptor agonist, influences various physiological processesPRAC concludes eye condition NAION is a very rare side .... Potential contributing factors could involve its effects on blood flow dynamics, coagulation, or inflammation within the optic nerve's vascular supply. Further research is needed to elucidate the precise Semaglutide NAION mechanism.

For individuals experiencing changes in their vision while on semaglutide, it is imperative to speak with your physicians, including your ophthalmologist and primary care physician. If NAION is confirmed, treatment with semaglutide should be stopped作者：CC Chou·2025·被引用次数：86—The findings suggest thatsemaglutide may not be associated with an increased risk of NAIONin the general population. Therefore, avoidance of semaglutide based .... Patients with pre-existing episodes of NAION should not be prescribed semaglutide, as a history of NAION in one eye increases the risk of recurrence.

In conclusion, while semaglutide offers significant therapeutic benefits for managing diabetes and obesity, a potential association with an increased risk of NAION has emerged作者：CX Cai·2025·被引用次数：86—The risk ofNAIONwas higher amongsemaglutideusers regardless of prior medication exposure compared with empagliflozin (both definitions) and .... The extent and implications of this risk are still being actively researched, with some studies indicating a higher risk, particularly in vulnerable populations, while others suggest no significant increase. Patients considering or currently using semaglutide should engage in open discussions with their healthcare providers about the potential benefits and risks, including any visual changes they may experience.佛历2568年6月6日—If NAION is confirmed,treatment with semaglutide should be stopped. More about the medicines. Semaglutide, a GLP-1 receptor agonist, is the ... Regular eye check-ups are advisable, especially for those with pre-existing risk factors for NAION.